21 CFR 1310.04 - Maintenance of records

Cite as21 CFR 1310.04
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
42 practice notes
  • Novelty Distributors, Inc. v. Leonhart, Civil Action No. 08-00635 (RMC).
    • United States
    • United States District Courts. United States District Court (Columbia)
    • June 17, 2008
    ...prevent illegal diversion of their products by proper handling, storage, and tracking. 21 U.S.C. §§ 830(a), (b)(1), 823(h); see also 21 C.F.R. §§ 1310.04, 1310.05(a), 1309.71-73. DEA has the authority to conduct inspections of registrants' places of business where regulated persons lawfully......
  • Novelty, Inc. v. D.E.A., No. 08-1296.
    • United States
    • United States Courts of Appeals. United States Court of Appeals (District of Columbia)
    • June 22, 2009
    ...maintained inaccurate records in violation of 21 U.S.C. § 830(a) (record keeping requirements for list I chemical transactions) and 21 C.F.R. § 1310.04.4 Id. Fourth, Novelty distributed ephedrine and pseudoephedrine products to retailers that were not self-certified as required by 21 U.S.C.......
  • Wedgewood Village Pharmacy v. D.E.A., No. 06-1156.
    • United States
    • United States Courts of Appeals. United States Court of Appeals (District of Columbia)
    • December 11, 2007
    ...handle between 25 and 1,000 grams of PPA during same time period). DEA charged that Wedgewood's handling this volume of PPA violated 21 C.F.R. § 1310.04 and other regulations. See Order to Show Cause 3 (JA 69) (citing, e.g., 21 C.F.R. § 1310.04 (imposing stricter record-keeping requirements......
  • Applications, hearings, determinations, etc.: Mediplas Innovations, Inc.,
    • United States
    • Federal Register June 17, 2002
    • June 17, 2002
    ...engages in a ``regulated transaction,'' then such [[Page 41264]] a transaction triggers recordkeeping and reporting requirements. See 21 CFR 1310.04 and 1310.05. Neither the statute nor the regulations provide limitations on the amount of List I chemicals a registered importer may sell to a......
  • Request a trial to view additional results
5 cases
  • Novelty, Inc. v. D.E.A., No. 08-1296.
    • United States
    • United States Courts of Appeals. United States Court of Appeals (District of Columbia)
    • June 22, 2009
    ...maintained inaccurate records in violation of 21 U.S.C. § 830(a) (record keeping requirements for list I chemical transactions) and 21 C.F.R. § 1310.04.4 Id. Fourth, Novelty distributed ephedrine and pseudoephedrine products to retailers that were not self-certified as required by 21 U.S.C.......
  • Novelty Distributors, Inc. v. Leonhart, Civil Action No. 08-00635 (RMC).
    • United States
    • United States District Courts. United States District Court (Columbia)
    • June 17, 2008
    ...prevent illegal diversion of their products by proper handling, storage, and tracking. 21 U.S.C. §§ 830(a), (b)(1), 823(h); see also 21 C.F.R. §§ 1310.04, 1310.05(a), 1309.71-73. DEA has the authority to conduct inspections of registrants' places of business where regulated persons lawfully......
  • Wedgewood Village Pharmacy v. D.E.A., No. 06-1156.
    • United States
    • United States Courts of Appeals. United States Court of Appeals (District of Columbia)
    • December 11, 2007
    ...handle between 25 and 1,000 grams of PPA during same time period). DEA charged that Wedgewood's handling this volume of PPA violated 21 C.F.R. § 1310.04 and other regulations. See Order to Show Cause 3 (JA 69) (citing, e.g., 21 C.F.R. § 1310.04 (imposing stricter record-keeping requirements......
  • U.S. v. Grab Bag Distributing, No. CIVF006132OWWSMS.
    • United States
    • United States District Courts. 9th Circuit. United States District Courts. 9th Circuit. Eastern District of California
    • February 15, 2002
    ...determining whether a receipt, sale, importation or exportation is a regulated transaction is" one kilogram for pseudoephedrine. 21 C.F.R. 1310.04(f). A. Failure to Identify Defendants admit to distributing pseudoephedrine, a listed chemical. See Doc.17 at p.4; Doc. 8. As such, they ar......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT